Advertisement

Ads Placeholder
Loading...

FONAR Corporation

FONR•NASDAQ
Healthcare
Medical - Devices
$18.59
$0.01(0.05%)
U.S. Market opens in 19h 7m

FONAR Corporation (FONR) Stock Overview

Explore FONAR Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap114.8M
P/E Ratio15.44
EPS (TTM)$1.15
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$17.52
3 Months$15.97
1 Year Target$15.10

FONR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of FONAR Corporation (FONR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.04, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $15.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.44 and a market capitalization of 114.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.05%
5-Day Change
0.22%
1-Month Change
0.49%
3-Month Change
0.38%
6-Month Change
15.61%
Year-to-Date (YTD) Change
0.38%
1-Year Change
34.71%
3-Year Change
17.07%
5-Year Change
-1.85%
All-Time (Max) Change
-84.51%

Contact Information

https://www.fonar.com
631 694 2929
110 Marcus Drive, Melville, NY, 11747

Company Facts

5,200 Employees
IPO DateOct 29, 1981
CountryUS
Actively Trading

Frequently Asked Questions